FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

Study: Drug, devicemaker ties with academic ctrs common

Tools
Tags
medical schools
Massachusetts General Hospital
academic medical centers
pharmaceutical companies
pharma
health policy

A new study suggests that academic medical centers have tight relationships with pharmas and medical-device makers, perhaps tighter than previously thought. The study, which was done by researchers at the Massachusetts General Hospital Institute for Health Policy, found that 67 percent of teaching hospital departments and 60 percent of department heads had a compensated relationship with a drug or device maker. Meanwhile, about 65 percent of medical schools had such relationships.

The relationships between these companies and academic medical centers included consulting relationships, speaking opps, advisory board memberships and intellectual property partnerships--not to mention education program funding and support for residency and fellowship training.

To learn more about the study:
- read this Modern Healthcare article

Related Articles:
Psychiatrists getting largest pharma gifts. Report
NY bill would require pharmas to report MD gifts. Report
NH ban on prescription data use overturned. Report
Doctors weigh in on pros and cons of accepting drug/device freebies. Letters
States tighten screws on pharma marketers. Report

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.